Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1Completed 1Active not recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Smoking 1Pulmonary Disease, Chronic Obstructive 1Overweight 1Obesity 1Noncommunicable Diseases 1Neoplasms 1Melanoma 1Hypokinesia 1Hypertension 1Hyperglycemia 1Dyslipidemias 1Diabetes Mellitus 1Coronary Disease 1Cerebrovascular Disorders 1Cardiotoxicity 1Asthma 1Alcohol Drinking 1

Interventions

Specimen Handling 3Blood Specimen Collection 2somapacitan 1pembrolizumab 1ibrutinib 1gallium 68 PSMA-11 1fluorodopa F 18 1exemestane 1durvalumab 1Tumor Burden 1Telemedicine 1Tamoxifen 1Standard of Care 1Semen Analysis 1Radiography, Panoramic 1Protons 1Physical Examination 1Photons 1Music Therapy 1Magnetic Resonance Spectroscopy 1Letrozole 1JNJ-64619178 1JNJ-64264681 1High-Intensity Interval Training 1Exercise 1Esophagectomy 1Electrocardiography 1Community Health Workers 1Angptl4 protein, mouse 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Neoplasms × Electrocardiography × Clear all
NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡